Postoperative Complications
Conditions
Brief summary
Impact of Local Anesthesia on Postbronchoscopy Fever: a Randomised Controlled Study
Detailed description
Fiberoptic bronchoscopy (FOB) is the essential procedures for diagnosis and treatment of respiratory diseases。 Fever following FOB has been frequently reported. Fever is usually caused by patient discomfort and delay recovery from illness, or even worse. The reported frequency of this complication ranges from 1 to 20%. According to previous reports, postbronchoscopy fever is associated with advanced age, the presence of abnormal bronchoscopic findings,documented endobronchial obstruction, bronchoscopic intervention for malignancy, BAL, bronchial brushing, endotoxin contamination during bronchoscopy, instillation of topical anesthetic through the bronchoscope, abnormal differential cell counts in the BAL fluid (BALF), bacterial growth in the BALF culture,and the severity of bleeding. At present, guidelines recommend sedation and analgesia combined with airway surface anesthesia for Fiberoptic bronchoscopy. laryngeal spray and cricothyroid anesthesia often used in clinical.Cricothyroid local anesthesia has a good effect, but it is an invasive operation, this is risk factors for fever after bronchoscopy.Therefore, to compare fever in the two kinds of airway anesthesia on Bronchoscopy . So as to provide the local anesthesia method with little influence on the patient.
Interventions
OTHERlocal surface anesthesia
Airway anesthesia for Bronchoscopy
DEVICELaryngeal tube
Sponsors
The Second Affiliated Hospital of Dalian Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* ASA I-III
Exclusion criteria
* use of immunosuppressive agents or corticosteroids * body temperature 37.3°C during the 24 h prior to FOB,intubation or mechanical ventilation * therapeutic bronchoscopy (foreign body removal, bronchial toilet, or stenting), discharge within 24 h of FOB * surgical or diagnostic procedures within 24 h of FOB.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fever | 48 hour | Fever was defined as an axillary body temperature 37.3°C |
Countries
China
Outcome results
None listed